6.300
−3,08%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +838.1% | +492.8% | 3 / 3 | +74.8% | +1.89 pp | +1.75 pp | +13.8% | 0.01 | 3.53 | 145 | +74,8% | 3,1 | +838,1% | 3.53 | 7.52 | −53,1% |
| Pts | 12 | 12 | 12 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.300 (close price on 2026-10-19)EPS (TTM): 1.787
Financial charts
1.Revenue & growth
VND bn145Q2/26
1.Revenue & growth
VND bn145Q2/26
2.Profit & growth
VND bn3,04Q2/26
3.Profit mix (Penman)
VND bn25,1Q2/26
4.Margins & cost structure
%8.2%Q2/26
5.Returns & cash cycle
% · days13.9%Q2/26
6.Earnings quality & cash
VND bn12,5Q2/26
7.Asset structure
VND bn212Q2/26
8.Funding & debt health
VND bn · times212Q2/26
9.Revenue backlog
VND bn12,9Q2/26
10.Valuation
times · %3,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %254Q2/26
Adjusted EPS growth, latest quarter
814%
Average adjusted EPS growth, 3 quarters
814%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26